Payment overview · 2025
General Payments
$27.97
1 reported records · 1 companies
Healthcare provider profile · identity verified
Olatz Ormazabal, MD
Allopathic & Osteopathic Physicians|Internal Medicine · YONKERS, NY · NPI 1255770699
Verified facts
What the public records show
CMS Open Payments records show Olatz Ormazabal, MD received $27.97 in general payments during 2025 across 1 reported records.
American Regent accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| American Regent | Unresolved — no canonical attribution shown | $27.97 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $27.97 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INJECTAFER Normalized: injectafer |
Drug | American Regent | $27.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 557 | 137 |
| Atorvastatin Calcium | Atorvastatin Calcium | 542 | 149 |
| Lisinopril | Lisinopril | 325 | 80 |
| Levothyroxine Sodium | Levothyroxine Sodium | 308 | 57 |
| Losartan Potassium | Losartan Potassium | 239 | 59 |
| Omeprazole | Omeprazole | 231 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 147 | 34 |
| Gabapentin | Gabapentin | 143 | 43 |
| Metformin Hcl | Metformin Hcl | 139 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 131 | 37 |
| Sertraline Hcl | Sertraline Hcl | 111 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 106 | 21 |
| Furosemide | Furosemide | 103 | 31 |
| Jardiance | Empagliflozin | 103 | 21 |
| Eliquis | Apixaban | 97 | 21 |
| Trazodone Hcl | Trazodone Hcl | 97 | 28 |
| Lorazepam | Lorazepam | 81 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 79 | 27 |
| Pantoprazole Sodium | Pantoprazole Sodium | 78 | 22 |
| Potassium Chloride | Potassium Chloride | 78 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 72 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 72 | 22 |
| Allopurinol | Allopurinol | 69 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 17 |
| Xarelto | Rivaroxaban | 69 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 68 | 11 |
| Tramadol Hcl | Tramadol Hcl | 64 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 59 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 58 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | 14 |
| Meloxicam | Meloxicam | 55 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 53 | 16 |
| Donepezil Hcl | Donepezil Hcl | 52 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 52 | 12 |
| Montelukast Sodium | Montelukast Sodium | 51 | 14 |
| Ozempic | Semaglutide | 48 | suppressed |
| Ezetimibe | Ezetimibe | 47 | 14 |
| Simvastatin | Simvastatin | 47 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 44 | 13 |
| Carvedilol | Carvedilol | 43 | suppressed |
| Synthroid | Levothyroxine Sodium | 42 | suppressed |
| Mirtazapine | Mirtazapine | 38 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 37 | 15 |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Estradiol | Estradiol | 34 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 33 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 14 |
| Alprazolam | Alprazolam | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Prednisone | Prednisone | 27 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Famotidine | Famotidine | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Clotrimazole | Clotrimazole | 24 | 14 |
| Ipratropium Bromide | Ipratropium Bromide | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | suppressed |
| Memantine Hcl | Memantine Hcl | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Acyclovir | Acyclovir | 21 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 16 |
| Fluconazole | Fluconazole | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Nystatin | Nystatin | 18 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Finasteride | Finasteride | 17 | suppressed |
| Spironolactone | Spironolactone | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 12 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Azithromycin | Azithromycin | 13 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Atenolol | Atenolol | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Neurontin | Gabapentin | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Zaleplon | Zaleplon | 12 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $27.97 · 1 records | American Regent | INJECTAFER | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error